| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 11 | 2014 | 1119 | 1.200 |
Why?
|
| Thyroglobulin | 6 | 2007 | 62 | 1.020 |
Why?
|
| Thyroiditis, Autoimmune | 4 | 2007 | 36 | 0.690 |
Why?
|
| Myocarditis | 3 | 2008 | 197 | 0.590 |
Why?
|
| Multiple Myeloma | 14 | 2014 | 2237 | 0.550 |
Why?
|
| Osteoclasts | 3 | 2013 | 160 | 0.540 |
Why?
|
| Autoimmune Diseases | 3 | 2008 | 418 | 0.540 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 37 | 0.520 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 69 | 0.520 |
Why?
|
| Zinc Fingers | 1 | 2016 | 214 | 0.500 |
Why?
|
| Bone Marrow Diseases | 1 | 2016 | 184 | 0.490 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 283 | 0.480 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 230 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 485 | 0.450 |
Why?
|
| Bone Marrow Cells | 4 | 2016 | 931 | 0.430 |
Why?
|
| Sequence Deletion | 1 | 2016 | 880 | 0.420 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 75 | 0.420 |
Why?
|
| Iodine | 3 | 2007 | 55 | 0.400 |
Why?
|
| Peyer's Patches | 1 | 2011 | 30 | 0.400 |
Why?
|
| Immune Tolerance | 3 | 2013 | 408 | 0.390 |
Why?
|
| Bone and Bones | 2 | 2016 | 604 | 0.380 |
Why?
|
| Mice | 35 | 2016 | 35331 | 0.380 |
Why?
|
| STAT1 Transcription Factor | 1 | 2011 | 159 | 0.370 |
Why?
|
| Autoantigens | 3 | 2007 | 238 | 0.360 |
Why?
|
| Receptor Cross-Talk | 1 | 2010 | 80 | 0.350 |
Why?
|
| RNA, Messenger | 3 | 2012 | 6224 | 0.350 |
Why?
|
| Thyroid Gland | 3 | 2007 | 358 | 0.340 |
Why?
|
| Interleukin-9 | 3 | 2014 | 37 | 0.340 |
Why?
|
| Lymphocyte Activation | 5 | 2010 | 1698 | 0.330 |
Why?
|
| Bone Marrow | 3 | 2016 | 2381 | 0.330 |
Why?
|
| Cell Differentiation | 10 | 2014 | 4168 | 0.330 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 290 | 0.320 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2014 | 1658 | 0.310 |
Why?
|
| Immune System | 1 | 2010 | 283 | 0.310 |
Why?
|
| Interferon-alpha | 2 | 2011 | 905 | 0.310 |
Why?
|
| Sodium Iodide | 1 | 2007 | 1 | 0.300 |
Why?
|
| Melanoma, Experimental | 3 | 2014 | 377 | 0.300 |
Why?
|
| Monoiodotyrosine | 1 | 2007 | 1 | 0.300 |
Why?
|
| Goiter | 1 | 2007 | 18 | 0.290 |
Why?
|
| Lymphocytes | 2 | 2008 | 1237 | 0.270 |
Why?
|
| Animals | 36 | 2016 | 61014 | 0.270 |
Why?
|
| Antigens | 1 | 2006 | 297 | 0.250 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 7429 | 0.250 |
Why?
|
| Hypothyroidism | 1 | 2007 | 208 | 0.250 |
Why?
|
| Mice, Inbred CBA | 5 | 2007 | 78 | 0.240 |
Why?
|
| Tyrosine | 1 | 2006 | 508 | 0.240 |
Why?
|
| Epitopes | 1 | 2007 | 696 | 0.240 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2014 | 1059 | 0.240 |
Why?
|
| Thymus Gland | 1 | 2005 | 298 | 0.230 |
Why?
|
| Immunophenotyping | 4 | 2016 | 1701 | 0.220 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 1615 | 0.210 |
Why?
|
| Lymphoma, Mantle-Cell | 3 | 2013 | 736 | 0.210 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2014 | 215 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2014 | 1506 | 0.210 |
Why?
|
| beta 2-Microglobulin | 2 | 2014 | 184 | 0.200 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 1471 | 0.200 |
Why?
|
| Cancer Vaccines | 3 | 2012 | 727 | 0.200 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2012 | 416 | 0.200 |
Why?
|
| Mice, SCID | 10 | 2014 | 1864 | 0.190 |
Why?
|
| Peptides | 1 | 2007 | 1504 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 345 | 0.190 |
Why?
|
| Major Histocompatibility Complex | 3 | 2010 | 95 | 0.180 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2012 | 209 | 0.180 |
Why?
|
| MicroRNAs | 1 | 2012 | 2955 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 8 | 2014 | 7173 | 0.160 |
Why?
|
| Diet | 1 | 2007 | 1476 | 0.160 |
Why?
|
| Apoptosis | 8 | 2014 | 7759 | 0.160 |
Why?
|
| Cell Lineage | 2 | 2012 | 705 | 0.140 |
Why?
|
| B-Lymphocytes | 4 | 2012 | 1353 | 0.140 |
Why?
|
| B7-H1 Antigen | 2 | 2014 | 1057 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2016 | 1288 | 0.140 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 7 | 0.140 |
Why?
|
| Cytokines | 5 | 2014 | 2871 | 0.140 |
Why?
|
| Coculture Techniques | 4 | 2014 | 632 | 0.140 |
Why?
|
| Side-Population Cells | 1 | 2016 | 18 | 0.140 |
Why?
|
| Antigens, Neoplasm | 3 | 2012 | 1559 | 0.130 |
Why?
|
| Interferon-gamma | 3 | 2014 | 1163 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 4 | 2014 | 4452 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2014 | 1891 | 0.130 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 4071 | 0.120 |
Why?
|
| Gene Expression | 3 | 2016 | 3594 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 512 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 9067 | 0.120 |
Why?
|
| Macrophages | 2 | 2012 | 1372 | 0.120 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2014 | 83 | 0.120 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2013 | 47 | 0.120 |
Why?
|
| Interleukin-6 | 3 | 2014 | 1057 | 0.120 |
Why?
|
| Immunity, Cellular | 2 | 2012 | 431 | 0.110 |
Why?
|
| Genes, Reporter | 1 | 2016 | 811 | 0.110 |
Why?
|
| Islets of Langerhans | 1 | 2014 | 232 | 0.110 |
Why?
|
| Adoptive Transfer | 2 | 2006 | 445 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 2 | 2010 | 1139 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 7 | 2014 | 5511 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 205 | 0.110 |
Why?
|
| Antigen Presentation | 2 | 2012 | 283 | 0.110 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2014 | 224 | 0.110 |
Why?
|
| CD11c Antigen | 1 | 2012 | 57 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2016 | 1182 | 0.110 |
Why?
|
| CD11b Antigen | 1 | 2012 | 66 | 0.110 |
Why?
|
| CD18 Antigens | 1 | 2012 | 82 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2016 | 573 | 0.100 |
Why?
|
| Leukocyte Common Antigens | 1 | 2012 | 190 | 0.100 |
Why?
|
| P-Selectin | 1 | 2012 | 125 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2013 | 3955 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 224 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2011 | 23 | 0.100 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2011 | 18 | 0.100 |
Why?
|
| Bone Resorption | 1 | 2012 | 137 | 0.100 |
Why?
|
| Peptide Fragments | 3 | 2007 | 1294 | 0.100 |
Why?
|
| Osteolysis | 1 | 2012 | 97 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 345 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 3666 | 0.100 |
Why?
|
| Tumor Escape | 1 | 2013 | 253 | 0.090 |
Why?
|
| Bone Diseases | 1 | 2012 | 140 | 0.090 |
Why?
|
| Vaccines, DNA | 1 | 2011 | 114 | 0.090 |
Why?
|
| STAT5 Transcription Factor | 1 | 2012 | 224 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2014 | 1018 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 624 | 0.090 |
Why?
|
| Leukopoiesis | 1 | 2010 | 7 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2016 | 5804 | 0.090 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2010 | 92 | 0.090 |
Why?
|
| Chemokine CXCL2 | 1 | 2010 | 35 | 0.090 |
Why?
|
| Morpholines | 1 | 2011 | 293 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2012 | 386 | 0.090 |
Why?
|
| Aminopyridines | 1 | 2011 | 219 | 0.090 |
Why?
|
| Immunoglobulin M | 1 | 2011 | 355 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2011 | 172 | 0.090 |
Why?
|
| Cell Proliferation | 8 | 2014 | 7303 | 0.090 |
Why?
|
| Granulocytes | 1 | 2010 | 232 | 0.090 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 154 | 0.090 |
Why?
|
| Mice, Inbred ICR | 2 | 2007 | 243 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2011 | 376 | 0.090 |
Why?
|
| Dexamethasone | 2 | 2011 | 1477 | 0.080 |
Why?
|
| Chromosomes, Mammalian | 1 | 2008 | 61 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2007 | 221 | 0.080 |
Why?
|
| Cardiac Myosins | 1 | 2008 | 18 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 592 | 0.080 |
Why?
|
| Interleukin-10 | 4 | 2013 | 491 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 670 | 0.080 |
Why?
|
| HLA-A2 Antigen | 1 | 2009 | 168 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1049 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 697 | 0.070 |
Why?
|
| Genotype | 1 | 2016 | 4168 | 0.070 |
Why?
|
| Tumor Microenvironment | 3 | 2014 | 2981 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 1111 | 0.070 |
Why?
|
| Thyroiditis | 1 | 2007 | 19 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2008 | 262 | 0.070 |
Why?
|
| Th1 Cells | 1 | 2008 | 259 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 2007 | 77 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 760 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 639 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1508 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 847 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 2341 | 0.070 |
Why?
|
| Signal Transduction | 7 | 2014 | 12151 | 0.070 |
Why?
|
| Thyroid Hormones | 1 | 2007 | 110 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2014 | 239 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 524 | 0.070 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2011 | 820 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2012 | 3596 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2011 | 717 | 0.060 |
Why?
|
| Neutrophils | 1 | 2010 | 845 | 0.060 |
Why?
|
| Cell Survival | 4 | 2014 | 3062 | 0.060 |
Why?
|
| Mice, Inbred NOD | 3 | 2014 | 902 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1183 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2006 | 266 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 5716 | 0.060 |
Why?
|
| Necrosis | 1 | 2006 | 598 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2006 | 275 | 0.060 |
Why?
|
| Stem Cells | 1 | 2011 | 1244 | 0.060 |
Why?
|
| Cell Line, Tumor | 7 | 2012 | 14855 | 0.060 |
Why?
|
| Biomarkers | 1 | 2016 | 5176 | 0.060 |
Why?
|
| Cell Communication | 3 | 2014 | 506 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 3148 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 4281 | 0.050 |
Why?
|
| Antibodies | 1 | 2006 | 843 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2005 | 850 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 2223 | 0.050 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 2012 | 51 | 0.050 |
Why?
|
| Up-Regulation | 3 | 2013 | 2480 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 1061 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 6127 | 0.050 |
Why?
|
| Humans | 18 | 2014 | 270843 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3294 | 0.050 |
Why?
|
| Myocardium | 1 | 2008 | 1335 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2012 | 5295 | 0.050 |
Why?
|
| Female | 10 | 2014 | 147292 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2012 | 5362 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2012 | 3074 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2006 | 5670 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2012 | 590 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2014 | 688 | 0.040 |
Why?
|
| Protein Binding | 1 | 2006 | 3483 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 2012 | 589 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 770 | 0.040 |
Why?
|
| Melphalan | 2 | 2012 | 839 | 0.040 |
Why?
|
| Stromal Cells | 2 | 2013 | 831 | 0.040 |
Why?
|
| Prognosis | 1 | 2016 | 22249 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2012 | 595 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 4776 | 0.040 |
Why?
|
| Kidney | 1 | 2005 | 2200 | 0.030 |
Why?
|
| Melanoma | 1 | 2012 | 5445 | 0.030 |
Why?
|
| Vaccination | 2 | 2011 | 1176 | 0.030 |
Why?
|
| Liver | 1 | 2005 | 2990 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 5242 | 0.030 |
Why?
|
| Immunotherapy | 3 | 2012 | 3481 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 2014 | 97 | 0.030 |
Why?
|
| Male | 8 | 2014 | 127630 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 3931 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 2014 | 136 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2014 | 292 | 0.030 |
Why?
|
| Receptors, CCR6 | 1 | 2012 | 22 | 0.030 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 39 | 0.030 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2012 | 19 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 692 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 91 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2012 | 77 | 0.030 |
Why?
|
| Receptors, OX40 | 1 | 2011 | 51 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 177 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2012 | 158 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2011 | 182 | 0.020 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2011 | 66 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2011 | 165 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2011 | 261 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 1533 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2011 | 84 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 509 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 296 | 0.020 |
Why?
|
| Receptors, Interleukin-8 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Thalidomide | 1 | 2014 | 577 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 342 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2010 | 54 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2010 | 53 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2010 | 104 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2014 | 667 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 200 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2011 | 317 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 11817 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 786 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 702 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 696 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1083 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 1411 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2009 | 139 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 14506 | 0.020 |
Why?
|
| Myosins | 1 | 2008 | 97 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 1233 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2011 | 1337 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 900 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 657 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 599 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 187 | 0.020 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 1069 | 0.020 |
Why?
|
| Hybridomas | 1 | 2007 | 72 | 0.020 |
Why?
|
| Immunization | 1 | 2008 | 402 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 2403 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 886 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 3144 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 675 | 0.020 |
Why?
|
| Caspases | 1 | 2008 | 685 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 471 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 1571 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1708 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 559 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 1585 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 835 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 183 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 1800 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2009 | 1410 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2010 | 2117 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3109 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 6245 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4245 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2011 | 2379 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 6404 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2007 | 3033 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 34238 | 0.010 |
Why?
|